DR Chi-leung CHIANG

蔣子樑醫生

MBChB (CUHK), FRCR (U.K.), FHKCR, FHKAM (Radiology), PDip Epidemiology and Biostatistics (CUHK)

Clinical Assistant Professor

E-mail: chiangcl@hku.hk

 

 

Biography:

Dr. Chiang Chi-leung graduated from The Chinese University of Hong Kong in 2004 and completed his specialist training at the Department of Clinical Oncology in Tuen Mun Hospital. He joined the Department of Clinical Oncology, LKS Faculty of Medicine HKU since January 2017. He has received overseas training in stereotactic radiation for hepato-biliary-pancreatic cancer at John Hopkins Hospital (USA) and Princess Margaret Hospital (Canada) in 2013. Later in 2015, he has pursued subspecialty training on the application of brachytherapy in gastrointestinal cancer in Jewish General Hospital (Canada). Besides, he obtained the Postgraduate Diploma in Epidemiology and Biostatistics (CUHK) in 2012.

Dr. Chiang is actively involved in the teacing of medical students and nurses. His main resarch and clinical interests include pancreatic cancer, colorectal cancer, and liver malignancy. He published peer review journal and presented at various local and international conferences.

 

Research Interest:

  1. Clinical application of stereotactic body radiotherapy (SBRT) in liver and pancreatic cancer
  2. Clinical application of brachytherapy in gastrointestinal cancer
  3. Personalized approach in treatment of rectal cancer

 

Selected Publications:

  • Mark KH Chan, Venus Lee, CL Chiang, Francis AS Lee, Gilbert Law, NY Sin, KL Siu, Frank CS Wong, Stewart Y Tung, Hollis Luk, Oliver Blanck. Lipiodol versus Diaphragm in 4D-CBCT-guided Stereotactic Radiotherapy of Hepatocellular Carcinom. Strahlentherapie und Onkologie (2016): 192:92-101.

  • Lee AS, Zee B, Cheung FY, Kwong P, Cheng A, Chiang CL, Leung KC, Siu S, Lee C, Lai M, Kwok C, Chong M, J Jolivet, Tung Y. Radomized Phase II study of the X-linked Inhibitor of Apoptosis (XIAP) Antisense AEG35156 in combination with Sorafenib in Patients with Advanced Hepatocellular Carcinoma (HCC). American Journal of Clinical Oncology 39(6): 609-613, December 2016.

  • CL Chiang, Venus W.Y. Lee, Cynthia S.Y. Yeung, Mathew Y.P. Wong, Francis A.S. Lee. External beam raidotherapy (EBRT) and High Dose Rate Brachytherapy (HDRBT) in Rectal Cancer Patients Who Are Medically Unfit or Refuse Surgery. Abstract presentation in 2017 ESTRO annual meeting.

  • WY Lee, YP Wong, CL Chiang, KH Chan, WK Leung, ML Law, AS Lee, Y Tung, DLW Kwong. Dosimetric Comparison Between MAR and Non-MAR CT Based HDR Endorectal Brachytherapy Using Shielded Intracavitary Mould Applicator. Oral presentation in World Congress of Brachytherapy 2016.

  • CL Chiang, AS Lee, KK Choi, SY Yueng, YP Wong, WK Leung, WY Lee, KH Chan, Y Tung. Stereotactic Body Radiotherapy (SBRT) combined with Transarterial Chemoembolization (TACE) in BCLC Stage B and C Hepatocellular Carcinoma (HCC). Abstract presentation in 2016 ASTRO annual meeting.

  • CL Chiang, AS Lee, KK Choi, CS Wong, WK Sze, Y Tung. Short course pre-operative radiotherapy with elective delayed surgery in rectal cancer: Report on our early experience, Oral presentation in 20th Hong Kong International Cancer Congress (2013).

  • Chiang CL, Lee AS, Choi KK, Wong CS, Sze WK, Tung Y. AFP Response as a Predictor for Clinical Outcome after Stereotactic Body Radiotherapy (SBRT) of Advanced HCC. Abstract presentation in 2nd ESTRO Forum 2013.

  • Lee AS, Wong V, Chiang CL, Choi C, Tung Y. Individualized hypofractionated radiation therapy (IHRT) for advanced HCC - Single Institution Experience with 98 patients. Abstract presentation in annual meeting of ASTRO 2012.